Welcome to the future of pharma
It’s an exciting time in this challenging, yet ever-evolving, field
In case you missed them, check out our collections on voices in chemistry, chemistry detectives, innovators, sustainability and health technology
Ion mobility spectrometry: the future of pharma analysis
Ion mobility spectrometry is transforming the field of biomolecule research, with Waters technology at the forefront of this vital analytical innovation
Ageing populations and the medicines of tomorrow
Drug particle engineering is set to revolutionise medicine and provide solutions to the world’s biggest healthcare challenges. Scientific innovator Nanoform is a vital part of that movement. Here’s why
Cultivating innovation in the UK’s life science industry
Scientific and digital collaboration is key to maintaining the UK’s esteemed status in global life sciences and pharma circles. CPI exists to facilitate and underpin those vital relationships
Artificial intelligence: on the cusp of a digital revolution
AI is transforming the pharma industry and its drug discovery pipeline
Pharma and healthcare meets data and digitalisation
UK-based company Life Science Integrates exists to facilitate collaboration between digital, pharma and life sciences industries – helping form partnerships that revolutionise healthcare
Pharma podcasts
Sofosbuvir
The hepatitis C drug that made waves when first launched – quicker to work and with fewer side effects than existing drugs, but it came with a hefty price tag
Source: © Shutterstock
US trade regulator sues to block Amgen–Horizon merger
Federal Trade Commission has concerns that union will allow Amgen to stifle potential competition for Horizon’s drugs
The diabetes drugs aiming to aid weight loss
Can peptide hormone mimics avoid the side effect pitfalls of previous weight loss treatments?
US supreme court confirms Amgen’s cholesterol antibody patents invalid
Decision could mean patent descriptions need to be even more detailed, and hence expensive
Regulators must follow their heads, not their hearts
The 2019 US approval of antibiotic Recarbrio seems not to have met the normally expected standards
Deadly explosion and fire at US pharmaceutical plant
One worker killed and four hospitalised at Seqens in Newburyport
Will a court overturn abortion drug’s approval?
Tangle between regulation and politics makes uncomfortable viewing from industry
